BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

691 related articles for article (PubMed ID: 23571104)

  • 1. Is complete lymph node dissection after a positive sentinel lymph node biopsy for cutaneous melanoma always necessary? A meta-analysis.
    Nagaraja V; Eslick GD
    Eur J Surg Oncol; 2013 Jul; 39(7):669-80. PubMed ID: 23571104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
    Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L
    Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The analysis of the outcomes and factors related to iliac-obturator involvement in cutaneous melanoma patients after lymph node dissection due to positive sentinel lymph node biopsy or clinically detected inguinal metastases.
    Zdzienicki M; Rutkowski P; Nowecki ZI; van Akkooi AC; Michej W; Dziewirski W; Świtaj T; Pieńkowski A; Sałamacha M; Bylina E; Eggermont AM
    Eur J Surg Oncol; 2013 Mar; 39(3):304-10. PubMed ID: 23298828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
    Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
    Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma.
    Sabel MS; Griffith K; Sondak VK; Lowe L; Schwartz JL; Cimmino VM; Chang AE; Rees RS; Bradford CR; Johnson TM
    J Am Coll Surg; 2005 Jul; 201(1):37-47. PubMed ID: 15978442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and location of positive nonsentinel lymph nodes in head and neck melanoma.
    Gyorki DE; Boyle JO; Ganly I; Morris L; Shaha AR; Singh B; Wong RJ; Shah JP; Busam K; Kraus D; Coit DG; Patel S
    Eur J Surg Oncol; 2014 Mar; 40(3):305-10. PubMed ID: 24361245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of nonsentinel lymph node involvement in patients with a positive sentinel lymph node in malignant melanoma.
    Page AJ; Carlson GW; Delman KA; Murray D; Hestley A; Cohen C
    Am Surg; 2007 Jul; 73(7):674-8; discussion 678-9. PubMed ID: 17674939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do micromorphometric features of metastatic deposits within sentinel nodes predict nonsentinel lymph node involvement in melanoma?
    Frankel TL; Griffith KA; Lowe L; Wong SL; Bichakjian CK; Chang AE; Cimmino VM; Bradford CR; Rees RS; Johnson TM; Sabel MS
    Ann Surg Oncol; 2008 Sep; 15(9):2403-11. PubMed ID: 18626721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In transit/local recurrences in melanoma patients after sentinel node biopsy and therapeutic lymph node dissection.
    Rutkowski P; Nowecki ZI; Zurawski Z; Dziewirski W; Nasierowska-Guttmejer A; Switaj T; Ruka W
    Eur J Cancer; 2006 Jan; 42(2):159-64. PubMed ID: 16324835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of the non-sentinel node risk score (N-SNORE) in patients with cutaneous melanoma and positive sentinel lymph nodes: a retrospective study.
    Feldmann R; Fink AM; Jurecka W; Rappersberger K; Steiner A
    Eur J Surg Oncol; 2014 Jan; 40(1):73-6. PubMed ID: 24075029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sentinel lymph node micrometastasis may predict non-sentinel involvement in cutaneous melanoma patients.
    Glumac N; Hocevar M; Zadnik V; Snoj M
    J Surg Oncol; 2008 Jul; 98(1):46-8. PubMed ID: 18452214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3).
    Nowecki ZI; Rutkowski P; Michej W
    Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological features of melanoma sentinel lymph node metastases associated with status of the completion lymphadenectomy and rate of subsequent relapse.
    Govindarajan A; Ghazarian DM; McCready DR; Leong WL
    Ann Surg Oncol; 2007 Feb; 14(2):906-12. PubMed ID: 17136471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is completion lymphadenectomy after a positive sentinel lymph node biopsy for cutaneous melanoma always necessary?
    Elias N; Tanabe KK; Sober AJ; Gadd MA; Mihm MC; Goodspeed B; Cosimi AB
    Arch Surg; 2004 Apr; 139(4):400-4; discussion 404-5. PubMed ID: 15078708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early (sentinel lymph node biopsy-guided) versus delayed lymphadenectomy in melanoma patients with lymph node metastases : personal experience and literature meta-analysis.
    Pasquali S; Mocellin S; Campana LG; Bonandini E; Montesco MC; Tregnaghi A; Del Fiore P; Nitti D; Rossi CR
    Cancer; 2010 Mar; 116(5):1201-9. PubMed ID: 20066719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related disparities in use of completion lymphadenectomy for melanoma sentinel lymph node metastasis.
    Shah DR; Yang AD; Maverakis E; Martinez SR
    J Surg Res; 2013 Nov; 185(1):240-4. PubMed ID: 23809182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis in patients with sentinel node-positive melanoma without immediate completion lymph node dissection.
    van der Ploeg AP; van Akkooi AC; Rutkowski P; Cook M; Nieweg OE; Rossi CR; Testori A; Suciu S; Verhoef C; Eggermont AM;
    Br J Surg; 2012 Oct; 99(10):1396-405. PubMed ID: 22961519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of a new scoring system for predicting non-sentinel node positivity in sentinel node-positive melanoma patients.
    Wevers KP; Murali R; Bastiaannet E; Scolyer RA; Suurmeijer AJ; Thompson JF; Hoekstra HJ
    Eur J Surg Oncol; 2013 Feb; 39(2):179-84. PubMed ID: 23137997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
    Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
    Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The predictive power of serum S-100B for non-sentinel node positivity in melanoma patients.
    Damude S; Hoekstra HJ; Bastiaannet E; Muller Kobold AC; Kruijff S; Wevers KP
    Eur J Surg Oncol; 2016 Apr; 42(4):545-51. PubMed ID: 26831006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.